Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

288 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Familial parkinsonism and ophthalmoplegia from a mutation in the mitochondrial DNA helicase twinkle.
Baloh RH, Salavaggione E, Milbrandt J, Pestronk A. Baloh RH, et al. Among authors: pestronk a. Arch Neurol. 2007 Jul;64(7):998-1000. doi: 10.1001/archneur.64.7.998. Arch Neurol. 2007. PMID: 17620490
OBJECTIVE: To describe the clinical phenotype and genetic basis of a family with autosomal dominant progressive external ophthalmoplegia and parkinsonism from a Twinkle mutation. ...SUBJECTS: Members of a 3-generation family followed up in a neuromuscu …
OBJECTIVE: To describe the clinical phenotype and genetic basis of a family with autosomal dominant progressive external ophthalmople …
Distal lower motor neuron syndrome with high-titer serum IgM anti-GM1 antibodies: improvement following immunotherapy with monthly plasma exchange and intravenous cyclophosphamide.
Pestronk A, Lopate G, Kornberg AJ, Elliott JL, Blume G, Yee WC, Goodnough LT. Pestronk A, et al. Neurology. 1994 Nov;44(11):2027-31. doi: 10.1212/wnl.44.11.2028. Neurology. 1994. PMID: 7969954
Polyneuropathies associated with high titre antisulphatide antibodies: characteristics of patients with and without serum monoclonal proteins.
Lopate G, Parks BJ, Goldstein JM, Yee WC, Friesenhahn GM, Pestronk A. Lopate G, et al. Among authors: pestronk a. J Neurol Neurosurg Psychiatry. 1997 Jun;62(6):581-5. doi: 10.1136/jnnp.62.6.581. J Neurol Neurosurg Psychiatry. 1997. PMID: 9219742 Free PMC article.
Patients with antisulphatide antibodies and a serum M protein, usually IgM, were more likely than patients without a serum M protein, to have syndromes with: (1) no pain or dysaesthesiae, (2) motor abnormalities, and (3) a demyelinating polyneuropathy by elec …
Patients with antisulphatide antibodies and a serum M protein, usually IgM, were more likely than patients without a serum M p …
Chronic immune demyelinating neuropathies.
Lopate G, Pestronk A. Lopate G, et al. Among authors: pestronk a. Semin Neurol. 1994 Jun;14(2):131-6. doi: 10.1055/s-2008-1041070. Semin Neurol. 1994. PMID: 7527153 Review.
Multifocal motor neuropathy: diagnosis and treatment.
Pestronk A. Pestronk A. Neurology. 1998 Dec;51(6 Suppl 5):S22-4. doi: 10.1212/wnl.51.6_suppl_5.s22. Neurology. 1998. PMID: 9851726 Review.
High titers of serum IgM binding to GM1 ganglioside, alone or in a membrane environment, occur in 80-90% of patients with MMN. ...
High titers of serum IgM binding to GM1 ganglioside, alone or in a membrane environment, occur in 80-90% of patients with MMN. ...
Myopathy with anti-Jo-1 antibodies: pathology in perimysium and neighbouring muscle fibres.
Mozaffar T, Pestronk A. Mozaffar T, et al. Among authors: pestronk a. J Neurol Neurosurg Psychiatry. 2000 Apr;68(4):472-8. doi: 10.1136/jnnp.68.4.472. J Neurol Neurosurg Psychiatry. 2000. PMID: 10727483 Free PMC article.
OBJECTIVE: To evaluate muscle pathology and clinical characteristics in patients with a myopathy and serum antibodies to the Jo-1 antigen (histidyl t-RNA synthetase). BACKGROUND: Anti-Jo-1 antibodies occur in syndromes that may include muscle weakness and pain, Raynaud's p …
OBJECTIVE: To evaluate muscle pathology and clinical characteristics in patients with a myopathy and serum antibodies to the Jo-1 ant …
Frequency of spinal arteriovenous malformations in patients with unexplained myelopathy.
Strom RG, Derdeyn CP, Moran CJ, Cross DT, Esper GJ, Mazumdar A, Al-Lozi M, Lopate G, Pestronk A. Strom RG, et al. Among authors: pestronk a. Neurology. 2006 Mar 28;66(6):928-31. doi: 10.1212/01.wnl.0000203501.88444.7a. Neurology. 2006. PMID: 16567716
TDP-43 accumulation in inclusion body myopathy muscle suggests a common pathogenic mechanism with frontotemporal dementia.
Weihl CC, Temiz P, Miller SE, Watts G, Smith C, Forman M, Hanson PI, Kimonis V, Pestronk A. Weihl CC, et al. Among authors: pestronk a. J Neurol Neurosurg Psychiatry. 2008 Oct;79(10):1186-9. doi: 10.1136/jnnp.2007.131334. J Neurol Neurosurg Psychiatry. 2008. PMID: 18796596 Free PMC article.
Treatment of IgM antibody associated polyneuropathies using rituximab.
Pestronk A, Florence J, Miller T, Choksi R, Al-Lozi MT, Levine TD. Pestronk A, et al. J Neurol Neurosurg Psychiatry. 2003 Apr;74(4):485-9. doi: 10.1136/jnnp.74.4.485. J Neurol Neurosurg Psychiatry. 2003. PMID: 12640069 Free PMC article. Clinical Trial.
Rituximab is a monoclonal antibody directed against the B cell surface membrane marker CD20. Rituximab eliminates B cells from the circulation, and, over time, could reduce cells producing autoantibodies. ...RESULTS: Treatment with rituximab was followed by improved streng …
Rituximab is a monoclonal antibody directed against the B cell surface membrane marker CD20. Rituximab eliminates B cells from the ci …
Myopathy with antibodies to the signal recognition particle: clinical and pathological features.
Miller T, Al-Lozi MT, Lopate G, Pestronk A. Miller T, et al. Among authors: pestronk a. J Neurol Neurosurg Psychiatry. 2002 Oct;73(4):420-8. doi: 10.1136/jnnp.73.4.420. J Neurol Neurosurg Psychiatry. 2002. PMID: 12235311 Free PMC article.
METHODS: Clinical, laboratory, and myopathological features were evaluated in seven consecutive patients with a myopathy and serum anti-SRP antibodies, identified over three years. ...Weakness became severe and disability developed rapidly over a period of months. M …
METHODS: Clinical, laboratory, and myopathological features were evaluated in seven consecutive patients with a myopathy and serum an …
288 results
Jump to page
Feedback